PRKN and Parkinson disease: Importantly, unlike most previously identified Parkin substrates, PARIS was shown to accumulate in post-mortem brain tissues derived from ARJP and sporadic PD patients, as well as in the ventral midbrain region of mice that is conditionally ablated of Parkin expression (Shin et al., 2011).